david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation..
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the. january 2017 (26)... october 2013 (25)